Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO-Asia-2020-Virtual-1000x250

Click on the links below to access the Industry Sponsored Satellite Symposia Invitations.

Friday 22 November 2019

Changing the Course for the Lung Cancer Patient: A New Direction

01-Changing-the-course-for-the-lung-cancer-patient-A-new-direction-ASTRAZENECA-Thumb

Friday, 12:45 - 14:15
View the satellite invitation

PARP Inhibitors as Targeted Therapy for Personalised Medicine

02-PARP-inhibitors-as-targeted-therapy-for-personalised-medicine-ASTRAZENECA-Thumb

Friday, 12:45 - 14:15
View the satellite invitation

From Clinical Trials to Practice: Changing the Trajectory for Metastatic Breast Cancer Patients

04-From-Clinical-Trials-to-Practice-Changing-the-Trajectory-for-Metastatic-Breast-Cancer-Patients-PFIZER-Thumb

Friday, 12:45 - 14:15
View the satellite invitation

Precision Oncology in Asia: A New Dawn or a False Hope?

Precision-Oncology-in-Asia-A-New-Dawn-or-a-False-Hope-ROCHE-thumb

Friday, 12:45 - 14:15
View the satellite invitation

A Quantum Leap in Treatment of NSCLC and HNSCC with IO

MSD Thumb

Friday, 12:45 - 14:15
View the satellite invitation

Saturday 23 November 2019

Evolving the Treatment Practice of Advanced EGFRm NSCLC

07-Evolving-the-treatment-practice-of-advanced-EGFRm-NSCLC-ASTRAZENECA-Thumb

Saturday, 12:45 - 14:15
View the satellite invitation

Treating EGFR+ NSCLC in 2020: New Approaches, Optimal Outcomes

08-Treating-EGFR-NSCLC-in-2020-New-Approaches-Optimal-Outcomes-PFIZER-Thumb

Saturday, 12:45 - 14:15
View the satellite invitation

Advances in Immune-Oncology: A Pan Tumor Perspective

MSD Thumb

Saturday, 12:45 - 14:15
View the satellite invitation

Evolving Treatment Landscape in ER+ Breast Cancer: Clinical Practice

10-Evolving-Treatment-Landscape-in-ER-Breast-Cancer-Clinical-Practice--NOVARTIS-Thumb

Saturday, 12:45 - 14:15
View the satellite invitation

Recent Advances and Future Possibilities with Immunotherapy in Renal and Urothelial Cancers

Merck-Pfizer Thumb

Saturday, 12:45 - 14:15
View the satellite invitation

Managing HCC Today: How Can We Give Our Patients the Best Chance?

12 Managing HCC Today: How Can We Give Our Patients the Best Chance? Thumb

Saturday, 12:45 - 14:15
View the satellite invitation

Sunday 24 November 2019

New Paradigm of Treatment Strategy for Intermediate and Advanced HCC

13-New-paradigm-of-treatment-strategy-for-intermediate-and-advanced-HCC-EISAI-Thumb

Sunday 11:00 - 12:30
View the satellite invitation

Cancer Immunotherapy in HCC: The Combination Revolution

14 - Cancer Immunotherapy in HCC: The Combination Revolution Thumb

Sunday 11:00 - 12:30
View the satellite invitation

Redefining ALK+ NSCLC Management

Redefining-ALK-NSCLC-Management-TAKEDA-thumb

Sunday 11:00 - 12:30
View the satellite invitation

The New Continuum of Care in mCRC

16-The-New-Continuum-of-Care-in-mCRC-MERCK-Thumb

Sunday 11:00 - 12:30
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.